Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder

There is a critical need for effective treatment of the core symptoms of autism spectrum disorder (ASD). The purinergic antagonist suramin may improve core symptoms through restoration of normal mitochondrial ...

Source: Annals of General Psychiatry - November 6, 2023 Category: Psychiatry Authors: David Hough, Alice R. Mao, Michael Aman, Reymundo Lozano, Constance Smith-Hicks, Veronica Martinez-Cerdeno, Michael Derby, Zachary Rome, Niel Malan and Robert L. Findling Tags: Research Source Type: research